Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Prodia Widyahusada TbkPRWDF 82 Price-to-Tangible-Book is 0.00 as of Aug. 26, 2026. GuruFocus rates PRWDF with a GF Score™ of 82/100. The stock has 1 warning sign investors should review. Among 151 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks better than 84.77% on this metric.
The historical rank and industry rank for PT Prodia Widyahusada Tbk's Price-to-Tangible-Book or its related term are showing as below:
PRWDF'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.96 Med: 2.09 Max: 4.32
Current: 1.07
During the past 13 years, PT Prodia Widyahusada Tbk's highest Price to Tangible Book Ratio was 4.32. The lowest was 0.96. And the median was 2.09.
PRWDF's Price-to-Tangible-Book is ranked better than 84.77% of 151
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.6
vs PRWDF: 1.07
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
PT Prodia Widyahusada Tbk Price-to-Tangible-Book Related Terms
PT Prodia Widyahusada Tbk Price-to-Tangible-Book Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRWDF vs TMO, DHR, IDXX: Price-to-Tangible-Book Comparison
For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Prodia Widyahusada Tbk Price-to-Tangible-Book vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where PT Prodia Widyahusada Tbk's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
PT Prodia Widyahusada Tbk (PRWDF) has a Price-to-Tangible-Book of 0.00 as of Aug. 26, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on PT Prodia Widyahusada Tbk and its competitors. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #23 out of 151 companies in the Medical Diagnostics & Research industry, placing it in the top 15.2%.
Is PT Prodia Widyahusada Tbk's Price-to-Tangible-Book too high?
PT Prodia Widyahusada Tbk's current Price-to-Tangible-Book is 0.00. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #23 out of 151 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's Price-to-Tangible-Book compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #23 out of 151 companies for Price-to-Tangible-Book. This places PT Prodia Widyahusada Tbk in the top 15% of its industry — outperforming the majority of peers. The industry median Price-to-Tangible-Book is 2.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Medical Diagnostics & Research company?
The median Price-to-Tangible-Book among Medical Diagnostics & Research companies is 2.60, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median Price-to-Tangible-Book is 2.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current Price-to-Tangible-Book is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
PT Prodia Widyahusada Tbk (PRWDF) has a current Price-to-Tangible-Book of 0.00. The current Price-to-Tangible-Book is 0.00. PT Prodia Widyahusada Tbk's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (PRWDF), the current Price-to-Tangible-Book is 0.00 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRWDF has been successfully added to your 
